Flash radiotherapy could replace conventional cancer treatments. It delivers radiation ultra-fast, reducing treatment ...

Attovia Therapeutics doses first participant in phase 1 study of ATTO-1310, its novel HLF anti-IL-31 ATTOBODY to treat chronic pruritus: Fremont, California Saturday, January 25, ...

Press Release ImmunoMet Therapeutics, Inc., ("ImmunoMet", or the "Company"), a clinical stage biotechnology company committed to giving patients a novel approach to fight cancer, today provided a data ...

Adolescents receive a weight-based dose equivalent to the 50 mg adult dose Adolescents 12-17 years old who complete participation in the pharmacokinetic (PK) run-in study will be eligible to screen in ...

JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy ...

Phase 2 randomized study of ELI-002 fully enrolled, with formal interim analysis of disease-free survival (“DFS”) expected in H1 2025; positive results could support rapid advancement into Phase 3 ...

A HUGE study that has been launched to find treatments for diseases by measuring how the proteins circulating in our bodies ...

Sana is a gene and cell therapy clinical-stage biotech firm and a penny stock that has fallen by 48.5% in the year leading to January 17, 2025. What may set this company apart from a host of similar ...

The Trump administration has a historic opportunity to secure the United States’ position as the 21st-century biopower.

Researchers at the Center for Advanced Bioenergy and Bioproducts Innovation (CABBI) have developed a new sorghum variant that ...

CABBI scientists have developed a lab-to-field pipeline to deliver sorghum that’s high in TAG. The researchers engineered ...

Celery, a key vegetable in the Apiaceae family, is widely valued for its nutrition and medicinal uses. It is commonly ...